ライフサイエンスコーパス: cervical dysplasia

コーパス検索結果 (１語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します

1 lear staining of beta-catenin in 18 cases of cervical dysplasia.

2 umerous HPV types, and frequently results in cervical dysplasia.

3 s also evidence for reduced gap junctions in cervical dysplasia.

4 may improve sensitivity in the detection of cervical dysplasia.

5 equired some form of destructive therapy for cervical dysplasia.

6 important early event in the development of cervical dysplasia.

7 ns targeting the vasculature in premalignant cervical dysplasia.

8 was also found in a subset of 10 high-grade cervical dysplasias.

9 human papillomavirus types and prevalence in cervical dysplasia and cancer in HIV-infected women sugg

10 wn to have diagnostic utility in identifying cervical dysplasia and carcinoma.

11 on of E7 caused the regression of high-grade cervical dysplasia and established cervical tumors, indi

12 a potentially important marker of high-grade cervical dysplasia and squamous cell carcinoma (SCC).

13 F of most patients with untreated high-grade cervical dysplasia but disappeared if the dysplasia was

14 tion of persistent cervical infection and of cervical dysplasia by these major oncogenic types.

15 High-grade cervical dysplasia caused by human papillomavirus (HPV)

16 , chondrodysplasia punctata, coronal clefts, cervical dysplasia, congenital cataracts, profound postn

17 genic HPV infection predicted progression of cervical dysplasia from normal to abnormal SIL (HR, 2.8;

18 human papillomavirus (QHPV) vaccine against cervical dysplasia has not been estimated using populati

19 umcision protecting against cervical cancer, cervical dysplasia, herpes simplex virus type 2, chlamyd

20 een and treat women for preinvasive disease, cervical dysplasia, is the key factor leading to the red

21 ubjects, at least 25% of HPV16(+) high-grade cervical dysplasia lesions undergo complete regression.

22 V) in the cervix, the proportion of cases of cervical dysplasia missed, or the false-negative rate, h

23 , and 7.4% of the methylprednisolone group), cervical dysplasia (seen in 11% of the cyclophosphamide

24 in these women suggests that the associated cervical dysplasia should be managed conservatively.

25 ent human papillomavirus (HPV) infection and cervical dysplasia than do HIV-uninfected women.

26 fectiveness (VE) of the QHPV vaccine against cervical dysplasia using data collected routinely in Man

27 shold of microvessel leakage associated with cervical dysplasia was <17 kDa and highlighted the poten

WebLSDに未収録の専門用語（用法）は "新規対訳" から投稿できます。